T1	Participants 702 740	A total of 116 patients were evaluable
T2	Participants 742 890	Of 55 patients in the chemotherapy arm, four (7%) had a complete response (CR) and 23 (42%) a partial response (PR) following the induction regimen.
T3	Participants 936 988	76% (42 of 55) of patients in the experimental group
T4	Participants 1012 1047	89% (54 of 61) in the control group
T5	Participants 1251 1316	Responders to chemotherapy did not fare better than nonresponders
